CollectionsAnimal Health
IN THE NEWS

Animal Health

FEATURED ARTICLES
NEWS
August 26, 2011 | By David Sell, Inquirer Staff Writer
Who loves puppies more? Merck or Pfizer? Both global pharmaceutical giants have animal-health divisions, but they are considering different paths. Merck Inc. just announced that it was bringing a Philly guy home - sort of - to run its animal kingdom, and chief executive officer Ken Frazier (another Philly guy) highlighted the unit's results in his opening statement to investment analysts when discussing second-quarter results. Pfizer Inc. said it was exploring the sale or spin-off of its animal unit and its human-nutrition division.
NEWS
July 7, 2011 | ASSOCIATED PRESS
NEW YORK - Pfizer Inc. said Thursday it may sell its animal health and nutrition business in the next two years so it can focus on expanding its low-cost pharmaceuticals unit. Pfizer, which has faced pressure to eliminate some business units and return more cash to shareholders, said the moves will allow investors to get more value for the businesses. The company will also consider transactions including spinoffs and may pursue different strategies for each business. Any transactions could take one to two years to complete, Pfizer said.
BUSINESS
December 20, 1996 | By Donna Shaw, INQUIRER STAFF WRITER
Make way for a new top dog: Merck & Co. Inc. and Rhone-Poulenc SA yesterday announced plans to combine resources and form the world's largest animal-health company. The new entity, to be called Merial Animal Health, will be a 50-50 joint venture between what already are two giants in veterinary and livestock medicines. Merck, a New Jersey pharmaceutical firm, and Rhone-Poulenc, a French chemical and drug maker, are numbers two and four respectively in the worldwide animal-health and poultry-genetics markets.
BUSINESS
November 24, 1994 | By Marian Uhlman, INQUIRER STAFF WRITER
SmithKline Beecham yesterday extended its string of billion-dollar deals this year to four by announcing the sale of its profitable worldwide animal- health business to Pfizer Inc. for $1.45 billion in cash. By shedding the animal-health operations, which are based in West Chester, SmithKline said it would be better able to focus on human health care. The deal will also reduce the firm's debt of $4.25 billion, which resulted, in part, from aggressive acquisitions this year. The purchase is expected to more than double Pfizer's annual animal-health sales to well over $1 billion.
BUSINESS
March 31, 1995 | By Vyola P. Willson, FOR THE INQUIRER
Pfizer Animal Health Group has decided to build, buy or lease a headquarters for its North American operations in Southeastern Pennsylvania, but it will be two months before it decides on a specific site. A company spokesman said yesterday that although there was a strong possibility Pfizer would choose to stay in Chester County, where it now has operations, the company was considering other sites. The decision is good news for 200 workers Pfizer acquired in a $1.45 billion buyout of SmithKline Beecham Animal Health in January.
NEWS
March 22, 1989 | Inquirer Harrisburg Bureau
According to some of his critics, Gov. Casey on occasion has submitted some inappropriate names for positions with state agencies or commissions. But not this time. The governor this week nominated to the new Animal Health and Diagnostic Commission an Ostrich, a Graybill and two Wolffs. That would be Sherbyn W. Ostrich, Robert E. Graybill, Dennis Wolff and state Agriculture Secretary Boyd E. Wolff. The task of the 15-member commission will be to combat livestock disease through the awarding of state grants and recommendations concerning animal health to the state legislature.
NEWS
December 11, 1994 | By Denise Breslin Kachin, INQUIRER CORRESPONDENT
After a long and friendly relationship, the township is losing a "good neighbor" and is hoping the new kid on the block will be just as good. The good neighbor who is leaving is SmithKline Beecham. In early 1995, Pfizer Inc. will take over SmithKline's animal-health research center on Paoli Pike, which has been in operation since the mid- 1960s. The East Goshen facility is part of SmithKline's animal-health business, which Pfizer purchased late last month for $1.45 billion.
NEWS
March 22, 2011 | ASSOCIATED PRESS
PARIS - Drugmakers Merck & Co. and Sanofi-Aventis SA on Tuesday abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles. Merck and Sanofi-Aventis say they've agreed that keeping their animal health businesses separate is in the best interests of the companies, their shareholders and their employees. "The companies are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process," the companies said in a joint statement.
BUSINESS
July 19, 2005 | By Thomas Ginsberg INQUIRER STAFF WRITER
Pfizer Inc. will take over a manufacturing site in Upper Merion from GlaxoSmithKline P.L.C. while production there is phased out, possibly in three years, both companies said yesterday. The lease agreement averts next year's scheduled closure and layoff of 230 employees, most of whom work on animal-health products. Pfizer agreed to provide GlaxoSmithKline employees "comparable benefits" for at least three years but gave no other details. "By continuing the production of our products at the Upper Merion facility, Pfizer will be able to ensure the consistent and seamless supply of its animal-health medications," Nat Ricciardi, president of Pfizer Global Manufacturing, said in a Pfizer statement.
BUSINESS
July 19, 2009 | By Miriam Hill, Inquirer Staff Writer
He's fat, neurotic, and unwittingly proffers his body as a romantic hideaway for vermin. And you love him so much that you spend hundreds or thousands of dollars yearly paying for pills, vaccines, and other products to keep him healthy. If this describes your relationship with your dog, you and your wallet know exactly why analysts expect companies bidding for the animal-health businesses of Pfizer Inc. and Merck & Co. Inc. to act like a pack of retrievers in hot pursuit of a drool-covered tennis ball: The market for these medicines is bounding.
1 | 2 | 3 | 4 | 5 | Next »
ARTICLES BY DATE
ENTERTAINMENT
June 7, 2013 | By Monica Peters, For The Inquirer
Have some presummer fun as the Ninth Annual Sugar Cane Festival, hosted by Asociación Puertorriqueños en Marcha and cosponsored by Peco, returns on Saturday with a day of information and activities on Fifth Street between Berks and Norris Streets. The day will offer community presentations, face painting, animals from the Philadelphia Zoo, and more. Performances include the Kensington CAPA (Creative and Performing Arts) Drum Corps, Fuego Dance Company, urban pop duo Domino Saints, and singer Franco Olivo.
BUSINESS
January 31, 2013 | By David Sell, Inquirer Staff Writer
Pfizer Inc. chief executive officer Ian Read said Tuesday that the world's largest seller of pharmaceutical products will keep examining whether to one day separate the management of its "innovative" drugs from "established" drugs, with patents that have expired. Since digesting the $69 billion acquisition of Wyeth in 2009, Pfizer has been trying to get the most it can from its business operations while negating the loss of revenue from blockbuster drugs such as Lipitor, which now has generic competition.
BUSINESS
June 9, 2012 | By David Sell and INQUIRER STAFF WRITER
Pfizer Inc. said Thursday that it would spin off its animal health unit and call the stand-alone company Zoetis. However, Pfizer will maintain control, so it was unclear how independent the new entity will be or how the differentiation will help Pfizer overall. Pfizer is based in Manhattan and has a big human pharmaceutical operation in Collegeville. The animal health unit has about 9,000 employees, with slightly more than 100 of them in Exton. Pfizer is preparing to file paperwork with the U.S. Securities and Exchange Commission for a potential stock offering in Zoetis, though the shares would represent a minority stake in the new company.
NEWS
August 26, 2011 | By David Sell, Inquirer Staff Writer
Who loves puppies more? Merck or Pfizer? Both global pharmaceutical giants have animal-health divisions, but they are considering different paths. Merck Inc. just announced that it was bringing a Philly guy home - sort of - to run its animal kingdom, and chief executive officer Ken Frazier (another Philly guy) highlighted the unit's results in his opening statement to investment analysts when discussing second-quarter results. Pfizer Inc. said it was exploring the sale or spin-off of its animal unit and its human-nutrition division.
NEWS
July 7, 2011 | ASSOCIATED PRESS
NEW YORK - Pfizer Inc. said Thursday it may sell its animal health and nutrition business in the next two years so it can focus on expanding its low-cost pharmaceuticals unit. Pfizer, which has faced pressure to eliminate some business units and return more cash to shareholders, said the moves will allow investors to get more value for the businesses. The company will also consider transactions including spinoffs and may pursue different strategies for each business. Any transactions could take one to two years to complete, Pfizer said.
NEWS
July 2, 2011
City School District and arithmetic Michael Masch, the CFO for the School District of Philadelphia, did a nice job of subterfuge in laying out the district's case for more funding ("Philly School District's spending under control," Tuesday). His analysis never even hints at one very glaring statistic: $2.7 billion. That's the budget for the district, down from $3.2 billion a few years ago. Deducting the funding for charter schools leaves $2.2 billion. With 25 percent of students now attending charters, that leaves approximately 120,000 other students left to educate.
NEWS
May 26, 2011
A new flare-up in Sudan dispute JUBA, Sudan - Gunmen from an ethnic Arab tribe allied with the Sudanese government of President Omar al-Bashir fired on four U.N. peacekeeping helicopters taking off from a disputed border town at the heart of a new north-south conflict, officials said Wednesday. None of the helicopters was hit. Both Sudan's north and south claim Abyei, in a fertile region that has oil fields. The dispute has complicated the planned creation in July of a new nation out of southern Sudan after the settlement of a long civil war. The black African Ngok Dinka tribe, allied with the south, and the Arab Misseriya, allies of the north, both claim the area, which was taken over by northern troops and tanks Saturday after an attack on a northern convoy earlier.
NEWS
March 22, 2011 | ASSOCIATED PRESS
PARIS - Drugmakers Merck & Co. and Sanofi-Aventis SA on Tuesday abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles. Merck and Sanofi-Aventis say they've agreed that keeping their animal health businesses separate is in the best interests of the companies, their shareholders and their employees. "The companies are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process," the companies said in a joint statement.
BUSINESS
July 19, 2009 | By Miriam Hill, Inquirer Staff Writer
He's fat, neurotic, and unwittingly proffers his body as a romantic hideaway for vermin. And you love him so much that you spend hundreds or thousands of dollars yearly paying for pills, vaccines, and other products to keep him healthy. If this describes your relationship with your dog, you and your wallet know exactly why analysts expect companies bidding for the animal-health businesses of Pfizer Inc. and Merck & Co. Inc. to act like a pack of retrievers in hot pursuit of a drool-covered tennis ball: The market for these medicines is bounding.
NEWS
June 2, 2009 | By Amy Worden INQUIRER STAFF WRITER
The Pennsylvania SPCA, which handles animal control for Philadelphia and is the state's largest operator of animal shelters, has named Susan Cosby its new chief executive officer. Cosby, 40, has served for 18 months as executive director of the Animal Welfare Association of New Jersey, a private shelter in Voorhees. While there, she established one of the state's top providers of spay/neuter services and helped reduce euthanasia rates by improving adoption rates. Before that post, she was chief operating officer for the now-defunct Pennsylvania Animal Care and Control, which until December 2008 handled animal-control matters for Philadelphia.
1 | 2 | 3 | Next »
|
|
|
|
|